Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$190,200
-1.06%
Shares
Shares Volume: 12,000 Shares
Average Share Price: $15.85
INSIDER
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER (Director)
reported on Jan 31 2024
traded on Jan 29 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,117,035 |
| PURCHASES/SALES 1Y | 0 / 6 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $140,001.59 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 26 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $472,329.57 |
| COMPANY PREVIOUS TRADES |